ASX - By Stock
|
HTG |
Re:
TA CHART
|
|
25or6to4
|
360 |
97K |
3 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
360
|
97K
|
3
|
|
ASX - By Stock
|
HTG |
Re:
Ann: December 2020 Quarterly Activities and Cash Flow Report
|
|
25or6to4
|
35 |
7.0K |
1 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
35
|
7.0K
|
1
|
|
ASX - By Stock
|
HTG |
Re:
Ann: Nodestream Downloadable Decoder Application
|
|
25or6to4
|
9 |
2.4K |
5 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
9
|
2.4K
|
5
|
|
ASX - By Stock
|
HTG |
Re:
Ann: HTG launches Three-Phase Corporate Strategic Plan
|
|
25or6to4
|
108 |
27K |
4 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
108
|
27K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Appendix 4C - quarterly
|
|
25or6to4
|
32 |
6.9K |
8 |
13/01/21 |
13/01/21 |
ASX - By Stock
|
32
|
6.9K
|
8
|
|
ASX - By Stock
|
HTG |
Re:
Ann: HTG launches Three-Phase Corporate Strategic Plan
|
|
25or6to4
|
108 |
27K |
4 |
13/01/21 |
13/01/21 |
ASX - By Stock
|
108
|
27K
|
4
|
|
ASX - By Stock
|
HTG |
Re:
Ann: Iristick & HTG agree to further develop smart safety glasses
|
|
25or6to4
|
43 |
7.0K |
2 |
07/01/21 |
07/01/21 |
ASX - By Stock
|
43
|
7.0K
|
2
|
|
ASX - By Stock
|
DW8 |
Re:
DW8 Growth
|
|
25or6to4
|
2.7K |
763K |
7 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
2.7K
|
763K
|
7
|
|
ASX - By Stock
|
HTG |
Re:
Ann: Pause in Trading
|
|
25or6to4
|
23 |
4.9K |
2 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
23
|
4.9K
|
2
|
|
ASX - By Stock
|
HTG |
Re:
Ann: Change of Director's Interest Notice
|
|
25or6to4
|
6 |
1.9K |
4 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
6
|
1.9K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Initial FDA and EMA Advice on Presendin Development
|
|
25or6to4
|
144 |
29K |
2 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
144
|
29K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Initial FDA and EMA Advice on Presendin Development
|
|
25or6to4
|
144 |
29K |
0 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
144
|
29K
|
0
|
|
ASX - By Stock
|
GSS |
Re:
GSS Analyst upgrade
|
|
25or6to4
|
21 |
7.3K |
7 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
21
|
7.3K
|
7
|
|
ASX - By Stock
|
HTG |
Re:
TA CHART
|
|
25or6to4
|
360 |
97K |
0 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
360
|
97K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Initial FDA and EMA Advice on Presendin Development
|
|
25or6to4
|
144 |
29K |
2 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
144
|
29K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Initial FDA and EMA Advice on Presendin Development
|
|
25or6to4
|
144 |
29K |
1 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
144
|
29K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Initial FDA and EMA Advice on Presendin Development
|
|
25or6to4
|
144 |
29K |
0 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
144
|
29K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Initial FDA and EMA Advice on Presendin Development
|
|
25or6to4
|
144 |
29K |
2 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
144
|
29K
|
2
|
|
ASX - By Stock
|
HTG |
Re:
Ann: June 2020 Quarterly Activities and Cash Flow Report
|
|
25or6to4
|
42 |
12K |
7 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
42
|
12K
|
7
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Initial FDA and EMA Advice on Presendin Development
|
|
25or6to4
|
144 |
29K |
2 |
26/07/20 |
26/07/20 |
ASX - By Stock
|
144
|
29K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Trading Halt
|
|
25or6to4
|
25 |
4.8K |
1 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
25
|
4.8K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Trading Halt
|
|
25or6to4
|
25 |
4.8K |
0 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
25
|
4.8K
|
0
|
|
ASX - By Stock
|
HTG |
Re:
TA CHART
|
|
25or6to4
|
360 |
97K |
5 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
360
|
97K
|
5
|
|
ASX - By Stock
|
HTG |
Re:
Defence Spending $270B
|
|
25or6to4
|
42 |
12K |
7 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
42
|
12K
|
7
|
|
ASX - By Stock
|
HTG |
Re:
Defence Spending $270B
|
|
25or6to4
|
42 |
12K |
4 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
42
|
12K
|
4
|
|
ASX - By Stock
|
HTG |
Re:
TA CHART
|
|
25or6to4
|
360 |
97K |
3 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
360
|
97K
|
3
|
|
ASX - By Stock
|
HTG |
Re:
Ann: Trading Halt
|
|
25or6to4
|
44 |
10K |
1 |
12/06/20 |
12/06/20 |
ASX - By Stock
|
44
|
10K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Andrew Twiggy Forrest buys 5 mill worth
|
|
25or6to4
|
68 |
18K |
4 |
07/06/20 |
07/06/20 |
ASX - By Stock
|
68
|
18K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Andrew Twiggy Forrest buys 5 mill worth
|
|
25or6to4
|
68 |
18K |
0 |
05/06/20 |
05/06/20 |
ASX - By Stock
|
68
|
18K
|
0
|
|
ASX - By Stock
|
HTG |
Re:
News: HTG Harvest Technology Group Appoints Jeffrey Sengelman As Independent Non-Exec Chairman
|
|
25or6to4
|
15 |
3.5K |
10 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
15
|
3.5K
|
10
|
|
ASX - By Stock
|
IXC |
Re:
Why Invex has all the right ingredients to possibly become a takeover target
|
|
25or6to4
|
4 |
1.8K |
4 |
30/05/20 |
30/05/20 |
ASX - By Stock
|
4
|
1.8K
|
4
|
|
ASX - By Stock
|
PPK |
Re:
PPK Chart
|
|
25or6to4
|
558 |
685K |
4 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
558
|
685K
|
4
|
|
ASX - By Stock
|
HTG |
Re:
TA CHART
|
|
25or6to4
|
360 |
97K |
1 |
04/05/20 |
04/05/20 |
ASX - By Stock
|
360
|
97K
|
1
|
|
ASX - By Stock
|
HTG |
Re:
TA CHART
|
|
25or6to4
|
360 |
97K |
1 |
04/05/20 |
04/05/20 |
ASX - By Stock
|
360
|
97K
|
1
|
|
ASX - By Stock
|
HTG |
Re:
TA CHART
|
|
25or6to4
|
360 |
97K |
0 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
360
|
97K
|
0
|
|
ASX - By Stock
|
PPK |
Re:
PPK Chart
|
|
25or6to4
|
558 |
685K |
6 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
558
|
685K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
Fifty one capital podcast episode on Invex
|
|
25or6to4
|
5 |
1.2K |
2 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
5
|
1.2K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
25or6to4
|
54 |
11K |
0 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
54
|
11K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
25or6to4
|
54 |
11K |
1 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
54
|
11K
|
1
|
|
ASX - By Stock
|
HTG |
Re:
TA CHART
|
|
25or6to4
|
360 |
97K |
3 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
360
|
97K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Cynata has manufacturing solution for new covd treatments
|
|
25or6to4
|
78 |
20K |
3 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
78
|
20K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Cynata has manufacturing solution for new covd treatments
|
|
25or6to4
|
78 |
20K |
7 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
78
|
20K
|
7
|
|
ASX - By Stock
|
HTG |
Re:
Ann: Change of Name and ASX Code
|
|
25or6to4
|
2 |
607 |
2 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
2
|
607
|
2
|
|
ASX - By Stock
|
PPK |
Re:
Updated target
|
|
25or6to4
|
318 |
93K |
1 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
318
|
93K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Market Update & Additional A$618k R&D Tax Refund
|
|
25or6to4
|
21 |
7.2K |
4 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
21
|
7.2K
|
4
|
|
ASX - By Stock
|
HTG |
Re:
Ann: 31 December 2019 Interim Report and Appendix 4D
|
|
25or6to4
|
3 |
73K |
1 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
3
|
73K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
25or6to4
|
507 |
1.5M |
3 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
507
|
1.5M
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Flag / pennant forming..?
|
|
25or6to4
|
23 |
8.8K |
0 |
14/10/19 |
14/10/19 |
ASX - By Stock
|
23
|
8.8K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Fujifilm Exercises License Option in GvHD
|
|
25or6to4
|
292 |
100K |
2 |
01/10/19 |
01/10/19 |
ASX - By Stock
|
292
|
100K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Dr-Borehams-crucible-is-cynata-therapeutics-fujifilm-partnership-all-puff-and-no-blow
|
|
25or6to4
|
30 |
8.4K |
2 |
07/05/19 |
07/05/19 |
ASX - By Stock
|
30
|
8.4K
|
2
|
|